Recombinant Plasmids and Bacterial Transformation: Production of Human Insulin

1. Introduction to Recombinant DNA Technology

• Recombinant DNA technology involves manipulating DNA to combine genetic material from different sources.
• This technology is crucial for producing proteins like human insulin in large quantities using bacteria.

KEY TAKEAWAY: Recombinant DNA technology allows us to harness bacteria as protein factories.

2. Plasmids as Vectors

• A vector is a DNA molecule used to carry foreign genetic material into another cell.
• Plasmids are small, circular DNA molecules found in bacteria, separate from the bacterial chromosome.
• Plasmids are ideal vectors because:
  • They can replicate independently within the bacterial cell.
  • They can be easily isolated and manipulated in vitro.
  • They often contain antibiotic resistance genes, which can be used for selection.

VCAA FOCUS: Understanding the properties of plasmids that make them suitable vectors is important.

3. The Process of Creating Recombinant Plasmids

1. Isolation of the Insulin Gene:
   • The human insulin gene is obtained. This can be done by:
     • Synthesizing the gene artificially based on the known amino acid sequence.
     • Isolating the gene from human cells using reverse transcriptase to create cDNA.
2. Plasmid Preparation:
   • A suitable plasmid vector is selected.
   • The plasmid is cut open using a restriction enzyme (also called restriction endonuclease).
   • Restriction enzymes recognize specific DNA sequences and cut the DNA at those sites. The same restriction enzyme must be used to cut the plasmid and the insulin gene to ensure complementary sticky ends are formed.
3. DNA Insertion:
   • The insulin gene is inserted into the cut plasmid.
   • The complementary “sticky ends” of the insulin gene and the plasmid base pair with each other.
4. Ligation:
   • DNA ligase is used to seal the sugar-phosphate backbones of the DNA fragments, creating a stable recombinant plasmid.

(Diagram description: A diagram showing a plasmid being cut by a restriction enzyme, the insulin gene being inserted, and DNA ligase sealing the gap.)

EXAM TIP: Be able to describe the roles of restriction enzymes and DNA ligase in creating recombinant plasmids.

4. Bacterial Transformation

• Transformation is the process by which bacteria take up foreign DNA from their environment.
• Competent cells: Bacteria are treated to make them more permeable to DNA (competent). Common methods include:
  • Heat shock: Briefly heating the bacteria to increase membrane permeability.
  • Electroporation: Using an electrical field to create temporary pores in the bacterial membrane.
• The recombinant plasmids are mixed with the competent bacterial cells.
• Some bacteria will take up the recombinant plasmids.

COMMON MISTAKE: Students often confuse transformation with transduction or conjugation. Transformation specifically refers to the uptake of naked DNA from the environment.

5. Selection of Transformed Bacteria

• The plasmid vector typically contains an antibiotic resistance gene.
• After transformation, the bacteria are grown on a medium containing the antibiotic.
• Only bacteria that have taken up the plasmid (and therefore have the antibiotic resistance gene) will survive.
• This allows for the selection of transformed bacteria.

(Diagram description: A petri dish showing bacterial colonies growing on a medium with antibiotics. Only the colonies that have taken up the plasmid containing the antibiotic resistance gene survive.)

STUDY HINT: Create a flow chart to visualize the steps of bacterial transformation and selection.

6. Production of Human Insulin

• The transformed bacteria are cultured in large fermenters.
• The insulin gene is expressed, and the bacteria produce human insulin.
• The insulin is then extracted and purified from the bacterial culture.
• The purified insulin is formulated into a pharmaceutical product for use by people with diabetes.

APPLICATION: Recombinant DNA technology has revolutionized the production of many therapeutic proteins, not just insulin.

7. Ethical Considerations

• Safety of Genetically Modified Organisms (GMOs): Concerns about the potential environmental and health impacts of GMOs.
• Access and Affordability: Ensuring that insulin and other life-saving drugs produced through recombinant DNA technology are accessible and affordable to all who need them.
• Informed Consent and Public Awareness: The importance of informing the public about genetically modified products and obtaining informed consent for their use.
• Animal Welfare: Addressing concerns about the use of animals in the production of biological materials.

REMEMBER: Ethical considerations are an integral part of biotechnology and must be carefully considered.

8. Summary Table

VCAA FOCUS: Be prepared to discuss the ethical considerations surrounding the use of recombinant DNA technology.